Dominique Bery
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Dominique Bery
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
37
| Public Company | Pharmaceuticals: Major | 37 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dominique Bery
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Biotechnology | Corporate Officer/Principal | |
| GAVI Alliance | Investment Trusts/Mutual Funds | Director/Board Member | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Antargaz SAS
 Antargaz SAS Gas DistributorsUtilities Antargaz SA distributes natural gas and provides related services. The firm sells gas and LPG fuel including natural gas, propane, butane in cylinders, through networks and tanks. The company was founded on September 8, 1988 and is headquartered in Paris, France. | Gas Distributors | Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer | |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Chief Executive Officer Corporate Officer/Principal | |
Compagnie Franco Tunisienne Des Petroles Cftp
 Compagnie Franco Tunisienne Des Petroles Cftp Contract DrillingIndustrial Services Compagnie Franco Tunisienne Des Petroles Cftp specializes in oil fields exploration activities. The private company is based in Sidi-El-Iteyem, Tunisia. | Contract Drilling | Director/Board Member | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
| University of St. Gallen | College/University | Masters Business Admin | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | President Director/Board Member | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen Pharmaceuticals, Inc.
 Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chairman Chairman Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer Director/Board Member | |
Manufacture Lorraine d'Optique Mont-Royal SARL
 Manufacture Lorraine d'Optique Mont-Royal SARL Medical SpecialtiesHealth Technology Manufacture Lorraine d'Optique Mont-Royal SARL manufactures and distributes eyeglasses and other ophthalmic goods. The firm’s products include Glasses for glasses, Glasses for Ultra HD glasses, Glasses for Natural glasses, Visiaz Driving Glasses HD, Visiaz Sport HD glasses for glasses, Glasses for glasses Visiaz XPro, Glasses for Visiaz glasses, Glasses for spectacles Visiaz DG, Glasses for Surf Glasses, Prescription Glasses, Glasses for glasses Solutions Bureau, Iceberg Evo+UV glass treatment and Azur UV glass treatment. The company is headquartered in Goetzenbruck, France. | Medical Specialties | Chairman | |
PricewaterhouseCoopers France SARL
 PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Callisto SAS
 Callisto SAS Investment ManagersFinance Callisto SAS provides financial advisory services to management teams for leveraged buy-outs. The private company is based in Paris, France. Hervé Couffin has been the CEO of the French company since 2005. | Investment Managers | Chief Executive Officer | |
| UNIQURE N.V. | Biotechnology | Chairman | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Ipsen Biopharmaceuticals, Inc. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chairman | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Chairman | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| MR HB SARL | Chief Executive Officer | ||
| Pbandco SAS | Chairman | ||
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Camping & Education Foundation | Director/Board Member | ||
Xinvento BV
 Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Biotechnology | Founder |
Statistik
International
| Vereinigte Staaten | 22 |
| Frankreich | 13 |
| Schweiz | 6 |
| Luxemburg | 3 |
| Kanada | 3 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 7 |
| Finance | 3 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 178 |
| Corporate Officer/Principal | 92 |
| Independent Dir/Board Member | 53 |
| Chairman | 29 |
| Chief Executive Officer | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Alexandre LeBeaut | 22 |
| Christophe Jean | 19 |
| David Meek | 19 |
| Ivana Magovcevic-Liebisch | 18 |
| Hélène Auriol-Potier | 18 |
| Pierre Martinet | 17 |
| Karen Witts | 17 |
| Howard Mayer | 16 |
| Margaret Liu | 15 |
| Christian Marcoux | 13 |
| Sotirios G. Stergiopoulos | 13 |
| Hervé Couffin | 12 |
| Richard Paulson | 12 |
| Piet Wigerinck | 10 |
- Börse
- Insiders
- Dominique Bery
- Unternehmensverbindungen